Practical approach to clinical controversies in glycemic control for hospitalized surgical patients. (30th April 2022)

• Record Type: Journal Article
• Authors: Ware, Lydia R.; Gilmore, James F.; Szumita, Paul M.
• Is Part Of: Nutrition in clinical practice. Volume 37:Number 3(2022)
• Page Start: 521
• Page End: 535
• Publication Date: 2022-04-30
• Subjects: critical illness -- hospitalization -- hyperglycemia -- hypoglycemia -- insulin -- surgery; Nutrition -- Periodicals; Diet therapy -- Periodicals; Artificial feeding -- Periodicals; 615.854
• DOI: 10.1002/ncp.10858
• Languages: English
• ISSNs: 0884-5336

Abstract

Abstract: The importance of glycemic management in surgical patient populations stems from an association between hyperglycemia and increased rates of surgical site infections, sepsis, and mortality. Various guidelines provide recommendations regarding target glucose concentrations, but all stress the importance of avoiding hypoglycemia as well. Within the surgical patient population, glycemic targets may vary further depending on the surgical service, such as cardiac surgery, neurosurgery, or reconstructive burn surgery. Glycemic management in critically ill surgical patients is achieved primarily through the use of intravenous insulin infusion protocols. These protocols can include fixed protocols, multiplication factor protocols, and computerized algorithms. In contrast, noncritically ill surgical patients are generally managed through the utilization of subcutaneous insulin with a combination of basal, bolus, and sliding scale insulin. Insulin protocols should be effective at maintaining glucose concentrations within the specified target range with minimal hypoglycemic events. Monitoring glucose concentrations while on either an intravenous or subcutaneous insulin protocol is essential. Point‐of‐care testing is the primary method for monitoring glucose concentrations in both critically ill and noncritically ill surgical patients and allows for adjustment of the insulin regimen. As patients move between units and to the outpatient setting, ensuring adequate follow‐up is essential to maintaining control of hyperglycemia.